-
Mashup Score: 33Acute changes in kidney function and outcomes following an acute myocardial infarction: Insights from PARADISE‐MI - 9 month(s) ago
Aims Pharmacologic blockade of neurohormonal pathways in patients with acute myocardial infarction (MI) can result in acute changes in biomarkers of kidney function. We evaluated the effect of sacub…
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2
#Calling #All #Zombies!: In the #Cheeky #Bastard’s #Catatonia – Kindle edition by Smith, William. Download it once and read it on your Kindle device, PC, phones or tablets. Use features like bookmarks, note taking and highlighting while reading #Calling #All #Zombies!: In the #Cheeky #Bastard’s #Catatonia.
Source: www.amazon.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @Psychgallica: The #Rump of #Paradise #Calling #All #Zombies! In the #Cheeky #Bastard’s #Catatonia https://t.co/pbs9LiwyV3
-
-
Mashup Score: 0ReCor Medical Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting - 3 year(s) ago
September 22, 2022 — ReCor Medical, Inc., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced the detailed results from the RADIANCE II US FDA IDE pivotal trial evaluating the endovascular Paradise Ultrasound Renal Denervation (uRDN) System as a treatment for hypertension. Principal Investigator Ajay J. Kirtane, MD, Professor of Medicine at Columbia University, Vagelos…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @ReCorMedical #Study of the #Paradise #Ultrasound #RenalDenervation System shows significant reduction in #bloodpressure in patients with uncontrolled #hypertension: https://t.co/PIdenEMFEV
-
-
Mashup Score: 0
BACKGROUND: Angiotensin-converting enzyme inhibitors attenuate left ventricular (LV) enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits with combined angio
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#OriginalResearch: In the #PARADISE-MI echo sub-study, sacubitril/valsartan vs ramipril did not result in change in LVEF or LAV but was associated w/ less LV enlargement & improved LV filling pressures at 8 mo post-AMI @AmilMShah #AHAJournals https://t.co/Pr33Py570z https://t.co/STIkdDJD80
-
-
Mashup Score: 1Amazon.com: #Biting a #Dentist: In the #Cheeky #Bastard's #Catatonia eBook : Smith, William: Kindle Store - 3 year(s) ago
Buy #Biting a #Dentist: In the #Cheeky #Bastard’s #Catatonia: Read Kindle Store Reviews – Amazon.com
Source: www.amazon.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @Psychgallica: The #Rump of #Paradise #Biting a #Dentist In the #Cheeky #Bastard’s #Catatonia https://t.co/QJUUvlv28r
-
-
Mashup Score: 4
Original Article from The New England Journal of Medicine — Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction
Source: New England Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet-
#Sacubitril–valsartan was not associated with a significantly lower incidence of death from CV causes or incident #HF than ramipril among patients with AMI ( #PARADISE-MI) https://t.co/pGuk8eVfQZ @NEJM @Drroxmehran @DLBHATTMD @NMHheartdoc @ErinMichos @CMichaelGibson @hvanspall https://t.co/cfKbBgH3jt
-
-
Mashup Score: 0
Dharam J. Kumbhani, MD, SM, FACC
Source: American College of CardiologyCategories: Cardiac Surgery, Latest HeadlinesTweet-
5/5 #PARADISE-MI enrolled similar pts <7 days after #AMI: Sac/Val did not reduce the primary outcome vs ramipril (HR 0.90 95%CI 0.78-1.04). An #Echo substudy is planned: https://t.co/U4RUYn3L5G #AHAJournals
-
-
Mashup Score: 3
Sacubitril valsartan (Entresto), deemed ‘the Big E’ by some clinicians, has fallen short in 2 of 3 clinical trials. The latest, presented at the ACC 2021 scientific session, is PARADISE-MI.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Sacubitril valsartan, deemed 'the Big E' by some clinicians, has fallen short in 2 of 3 clinical trials. The latest, presented at the #ACC2021 scientific session, is #PARADISE-MI. https://t.co/eGTyey6IQ8 https://t.co/MconUDH0kO
-
-
Mashup Score: 0
Sacubitril valsartan (Entresto), deemed ‘the Big E’ by some clinicians, has fallen short in 2 of 3 clinical trials. The latest, presented at the ACC 2021 scientific session, is PARADISE-MI.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Perhaps a lesson from #PARADISE-MI: new drugs for common conditions ought to require two confirmatory trials before widespread clinical acceptance. https://t.co/ok5b2anVWZ #ACC21 via @drjohnm https://t.co/w6FMWaIAYW
-
-
Mashup Score: 0ACC Scientific Session Program Planner | Session - 4 year(s) ago
Powered by cOASIS, The Online Abstract Submission and Invitation System SM © 1996 – 2021 CTI Meeting Technology – All rights reserved. Privacy Policy Feedback
Source: www.abstractsonline.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Interested in taking a deep dive into late-breaking clinical trials presented at #ACC21? Tune into this session starting at 4:45 p.m. ET: https://t.co/BvJj1ose4H #PARADISE #LAAOS #ATLANTIS https://t.co/n7B0mXQL92
-
Acute changes in kidney function and outcomes following an acute myocardial infarction: Insights from #PARADISE-MI https://t.co/5iKCMr0h9l @ESC_Journals @EJHFEiC @HFA_President @AmrAbdin10 @mmamas1973 @ShelleyZieroth @GiuseppeGalati_ @WilfriedMullens https://t.co/8LXV0qDhc2 https://t.co/FBNWLFly5P